January 5, 2016

Paroxetine Linked With Increased Risk of Birth Defects When Taken in Early Pregnancy

HOBOKEN, NJ -- January 5, 2016 -- Using paroxetine during the first trimester of pregnancy may increase newborns’ risk of congenital malformations and cardiac malformations, according to a study published in the British Journal of Clinical Pharmacology.

A small unpublished study conducted by the manufacturer of paroxetine suggested an increased risk of cardiac malformations in infants exposed to paroxetine before birth. Subsequent studies using various study designs in different populations across Europe and North America generated conflicting results in terms of statistical significance, although a trend remained towards an increased risk.

To provide a comprehensive assessment of the effects of paroxetine on newborns, Anick Bérard, PhD, CHU Sainte-Justine and the University of Montreal, Montreal, Quebec, conducted a literature review and meta-analysis of all relevant studies published from 1966 to 2015. The investigators uncovered 23 eligible studies.

Compared with no use of paroxetine, first trimester use of paroxetine was associated with a 23% increased risk of any major congenital malformations and a 28% increased risk of major cardiac malformations in newborns.

The investigators noted that the baseline risk of major malformations is 3% and of cardiac malformations is 1%; however, any increase in risk is significant, especially when considering that the benefit of using selective serotonin reuptake inhibitors during pregnancy -- when changes in metabolism cause the drugs to be cleared from the body at a faster rate -- is debatable.

“Given that the benefits of antidepressants overall, and selective serotonin reuptake inhibitors including paroxetine specifically, during pregnancy is questionable at best, any increase in risk -- small or large -- is too high,” said Dr. Bérard. "Indeed, the risk/benefit ratio suggests non-use in women with mild to moderately depressive symptoms, which is 85% of pregnant women with depressive symptoms. Therefore, planning of pregnancy is essential, and valid treatment options such as psychotherapy or exercise regimens are warranted in this special population.”

SOURCE: Wiley
Log in or register to post comments

DG News saves you time by delivering a short list of medical developments worthy of your time and attention. Our advanced algorithms rank clinical content based on hundreds of data points to surface the most important medical advances impacting your practice each week.